Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane, ((-)-BPAP), a highly potent and selective catecholaminergic activity enhancer.
暂无分享,去创建一个
[1] D. M. Weinstein,et al. Design and synthesis of enantiomers of 3,5-dinitro-o-tyrosine: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonists. , 1998, Journal of medicinal chemistry.
[2] J. Knoll,et al. (-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain. , 1998, Pharmacology & toxicology.
[3] J. Knoll. Sexual performance and longevity , 1997, Experimental Gerontology.
[4] T. Eisner,et al. Absolute configuration of insect-produced epilachnene , 1997 .
[5] J. Knoll,et al. Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: rationale for prophylactic (-)deprenyl (selegiline) medication. , 1995, Life sciences.
[6] P. Edwards,et al. Peptidyl alpha-ketoheterocyclic inhibitors of human neutrophil elastase. 2. Effect of varying the heterocyclic ring on in vitro potency. , 1995, Journal of medicinal chemistry.
[7] J. Knoll. Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes. , 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[8] J. Knoll. Memories of my 45 years in research. , 1994, Pharmacology & toxicology.
[9] W. Tatton,et al. Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism , 1991, Journal of neuroscience research.
[10] J. Langston,et al. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. , 1989, Science.
[11] Anthony E. Lang,et al. Effect of deprenyl on the progression of disability in early Parkinson's disease. , 1989, The New England journal of medicine.
[12] J. Knoll. The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenyl , 1988, Mechanisms of Ageing and Development.
[13] A. Treasurywala,et al. Enantiomeric effects of homologues of disoxaril on the inhibitory activity against human rhinovirus-14. , 1988, Journal of medicinal chemistry.